Laddar...
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70–80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food and Dru...
Sparad:
| I publikationen: | Medicina (Kaunas) |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
MDPI
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843273/ https://ncbi.nlm.nih.gov/pubmed/31627433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55100698 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|